UPDATE: Bank Of America Downgrades Seattle Genetics, Inc. On Frontline Expectations

By: via Benzinga
In a report published Tuesday, Bank of America analyst Steve Byrne downgraded the rating on Seattle Genetics, Inc. (NASDAQ: SGEN) from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.